RIKADA is a prospective study performing systematic family screening including clinical and genetic testing in pediatric patients with primary cardiomyopathy and their first-degree relatives with the aim to facilitate risk stratification.
See this in plain English?
AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.
major cardiovascular events
Timeframe: from date of enrollment until the date of death, mechanical circulatory support or heart transplantation, assessed up to 8 years